GREENLAND MINES LTD Temporary Equity, Accretion to Redemption Value
GREENLAND MINES LTD (GRML) reported Temporary Equity, Accretion to Redemption Value of $254.59 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-23.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityAccretionToRedemptionValue · last filed 2024-05-23
- GREENLAND MINES LTD temporary equity, accretion to redemption value for the quarter ending 2024-03-31 was $254.59K, a 80.74% decline year-over-year.
- GREENLAND MINES LTD temporary equity, accretion to redemption value for the quarter ending 2023-09-30 was $679.97K, a 48.27% increase year-over-year.
- GREENLAND MINES LTD temporary equity, accretion to redemption value for the quarter ending 2023-06-30 was $1.01M, a 96.20% decline year-over-year.
- GREENLAND MINES LTD temporary equity, accretion to redemption value for the quarter ending 2023-03-31 was $1.32M.
- GREENLAND MINES LTD temporary equity, accretion to redemption value for fiscal 2023 was $3.63M, a 87.66% decline from fiscal 2022.
- GREENLAND MINES LTD temporary equity, accretion to redemption value for fiscal 2022 was $29.39M.
| Period end | Temporary Equity, Accretion to Redemption Value 3 month | Temporary Equity, Accretion to Redemption Value 6 month | Temporary Equity, Accretion to Redemption Value 9 month | Temporary Equity, Accretion to Redemption Value 12 month |
|---|---|---|---|---|
| 2024-03-31 | $254.59K 10-Q · filed 2024-05-23 | |||
| 2023-12-31 | $3.63M 10-K · filed 2024-04-17 | |||
| 2023-09-30 | $679.97K 10-Q · filed 2023-11-17 | $1.69M derived: sum of 2 quarters · filed 2023-11-17 | $3.02M derived: sum of 3 quarters · filed 2024-05-23 | |
| 2023-06-30 | $1.01M 10-Q · filed 2023-11-17 | $2.34M derived: sum of 2 quarters · filed 2024-05-23 | ||
| 2023-03-31 | $1.32M 10-Q · filed 2024-05-23 | |||
| 2022-12-31 | $29.39M 10-K · filed 2024-04-17 | |||
| 2022-09-30 | $458.60K 10-Q · filed 2023-11-17 | $27.17M derived: sum of 2 quarters · filed 2023-11-17 | ||
| 2022-06-30 | $26.71M 10-Q · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |